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Knockdown of p66Shc Alters Lineage-Associated
Transcription Factor Expression in Mouse Blastocysts
Nicole A. Edwards,1 Andrew J. Watson,1–3 and Dean H. Betts1–3

The p66Shc adaptor protein regulates apoptosis and senescence during early mammalian development. However,
p66Shc expression during mouse preimplantation development is upregulated at the blastocyst stage. Our objective
was to determine the biological function of p66Shc during mouse blastocyst development. In this study, we demonstrate that a reduced p66Shc transcript abundance following its short interfering RNA (siRNA)-mediated
knockdown alters the spatiotemporal expression of cell lineage-associated transcription factors in the inner cell mass
(ICM) of the mouse blastocyst. P66Shc knockdown blastocysts restrict OCT3/4 earlier to the inner cells of the early
blastocyst and have ICMs containing significantly higher OCT3/4 levels, more GATA4-positive cells, and fewer
NANOG-positive cells. P66Shc knockdown blastocysts also show a significantly reduced ability to form ICMderived outgrowths when explanted in vitro. The increase in cells expressing primitive endoderm markers may be due
to increased ERK1/2 activity, as it is reversed by ERK1/2 inhibition. These results suggest that p66Shc may regulate
the relative abundance and timing of lineage-associated transcription factor expression in the blastocyst ICM.
Keywords: p66Shc, blastocyst, epiblast, inner cell mass, MAPK, primitive endoderm
Introduction

M

ouse preimplantation embryo development results
in the formation of a blastocyst containing three distinct cell types: the trophectoderm (TE), the primitive endoderm (PE), and the epiblast (EPI). Postimplantation, the
TE and PE form extraembryonic structures, whereas the EPI
will contribute to the fetal germ layers and germ cells. Proper
specification of these three cell lineages requires spatiotemporal activation of signaling pathways that promote the
expression of lineage-specific markers, some of which are
required to maintain cell fate and identity.
Studies show that in the 8–16 cell embryo, the Hippo signaling pathway is the main signaling pathway critical to establishing TE versus inner cell mass (ICM) cell identity by
regulating the expression of the TE-specific marker CDX2 [1–3].
In the blastocyst, differential fibroblast growth factor 4 (FGF4)/
mitogen-activated protein kinase (MAPK) signaling drives the
acquisition of an EPI or PE fate in the ICM by regulating the
expression of the EPI marker NANOG and the PE markers
GATA6, SOX17, and GATA4 [4–7]. Disrupting components of
either signaling pathway results in aberrant cell fate specification
and failure to maintain embryonic development postimplantation, or failure to generate lineage-specific stem cells [2–4,8].

Of these signaling pathway components, receptor tyrosine kinase (RTK) signaling in response to FGF4 binding is
required for PE cell fate determination. Growth factor receptorbound protein 2 (GRB2) is an adaptor protein linking activated
RTKs to Ras/MAPK signaling. Grb2 knockout (KO) embryos
have ICMs containing no PE cells as identified by the absence of
Gata6 expression. Instead, all cells of Grb2 KO blastocyst ICMs
are NANOG positive [9]. These results therefore demonstrate
that MAPK signaling downstream of RTK activation is required
for expression of PE-specific markers and PE specification.
Similarly, embryos treated with the extracellular signalregulated kinase (ERK) inhibitors from the 8-cell to the blastocyst stage generate ICMs containing all EPI cells [5,7].
However, this phenotype is partially reversible if the inhibitor
is removed by embryonic day 3.75 (E3.75), indicating that
ICM cells maintain plasticity until E4.0–E4.5 [5]. Similarly,
cell aggregation experiments showed that ICM cells lose this
plasticity by E4.5 [10]. Thus, MAPK signaling is important
for stabilizing PE specification in the blastocyst until commitment occurs just before implantation.
Another RTK signaling pathway component expressed in
many cell types is the family of SHC1 adaptor proteins. All
Shc1 isoforms contain a common phosphotyrosine-binding
domain that associates with activated RTKs, but unlike
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p52Shc, p66Shc does not activate downstream Ras-MAPK
signaling [11,12]. A unique function of p66Shc is in the response to oxidative stress attributed to serine/threonine sites
on an N-terminal extension. Under conditions of oxidative
stress, p66Shc is phosphorylated at serine-36, translocates to
the mitochondria, and promotes the release of reactive oxygen
species (ROS), leading to apoptosis [13]. We have demonstrated that p66Shc is basally expressed in mouse preimplantation embryos, is upregulated at the blastocyst stage, and
that its expression is modulated by the culture environment
[14]. Loss of function studies using RNA interference (RNAi)
showed that p66Shc promotes apoptosis and senescence associated with an increase in ROS in cow and mouse embryos
exposed to stress-inducing environmental conditions [15–
17]. However, whether p66Shc has a biological function that
is required to ensure proper preimplantation development,
remains unknown.
Due to its role in RTK/MAPK signaling in other cell types,
we hypothesized that p66Shc is a regulatory component in the
pathways underlying blastocyst cell lineage specification.
Thus, the objective was to determine the role of p66Shc in
mouse blastocyst development using short interfering RNA
(siRNA) knockdown in mouse preimplantation embryos. Our
results show that mouse embryos with decreased p66Shc levels
formed blastocysts with faster restriction to and higher levels
of OCT3/4 in the inner cells, had an earlier onset of GATA4
expression, and earlier sorting of PE cells to the PE layer.
P66Shc knockdown ICMs contained significantly more cells
expressing PE markers (GATA4, SOX17) than cells expressing EPI markers (NANOG), associated with an increase in
cells expressing the ERK1/2 transcriptional target DUSP4.
Thus, we have uncovered a novel role for p66Shc associated
with the timing and expression of lineage-associated transcription factors in the ICM of mouse blastocysts.

Materials and Methods
Animal source and ethical approval
Female and male wild-type CD1 mice were obtained from
Charles River Canada (Saint-Constant, Quebec, Canada).
Mice were housed with a 12-h light/12-h dark cycle and access
to food and water ad libitum. All experimental protocols were
approved by the University of Western Ontario Animal Care
and Veterinary Services and the Canadian Council of Animal
Care (protocol Watson no. 2010-021). For all experiments,
mice were euthanized by CO2 asphyxiation.
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washes in embryo culture medium (potassium simplex optimized media with amino acids, KSOMaa; Zenith Biotech).
Embryos were cultured in KSOMaa in a 5% O2, 5% CO2, 90%
N, 37C humidified incubator.
Zygotes underwent a recovery period for a minimum of 1 h
after collection before microinjection. Postinjection, mouse
embryos were cultured for up to 120 h post siRNA injection
in KSOMaa in a 5% O2, 5% CO2, 90% N, 37C humidified
incubator. For MEK inhibitor experiments, embryos were incubated in KSOMaa containing 1 mM PD0325901 (Selleck
Chemicals) or DMSO (vehicle control; Sigma-Aldrich) for
24 h. For the in vitro blastocyst outgrowth assay, the zona
pellucida was removed by briefly incubating blastocysts in
Acidic Tyrode’s Solution (Sigma-Aldrich). One to three blastocysts were transferred to one well of an eight-well chamber
slide (Ibidi) on a feeder layer of irradiated mouse embryonic
fibroblasts (ATCC, Canada). Embryos were cultured for 4 days
in KO DMEM/F12 containing 20% KO Serum Replacement
(Life Technologies, Canada), 1% GlutaMAX (Life Technologies), nonessential amino acids, 55 mM b-mercaptoethanol, and
1,000 U/mL mouse LIF (Sigma-Aldrich).

Cytoplasmic microinjection of siRNA
Short interfering RNA (siRNA) oligonucleotide sequences
targeting the mouse p66Shc transcript and scrambled control
targets were designed by us (see Table 1 for sequences), then
synthesized by Thermo Fisher Scientific (Silencer Select
siRNA, Canada). SiRNA were stored at -20C as a 100 mM
stock and diluted in nuclease-free water. Diluted siRNA solutions were back filled into Femtotips (outside diameter
1 mM; Eppendorf, Germany). Mouse zygotes were held in M2
medium overlaid with embryo culture grade oil (Zenith
Biotech) during injection periods. The cytoplasm of mouse
zygotes was injected with 10 pl of 50 mM of either p66Shcspecific or scrambled sequence siRNA using a FemtoJet
Microinjector (Eppendorf) at the following settings: injection
pressure 75 hPa, injection time 0.1 s, and constant pressure
15 hPa [15]. After injection, mouse zygotes were placed into
KSOMaa and any embryos that had lysed were immediately
removed from culture. Twenty zygotes were injected at a
time, then moved to a 5% CO2, 37C humidified incubator,
until all injections were completed.

Mouse embryonic stem cell transfection
R1 mouse embryonic stem cells (Sick Kids, Toronto,
Canada) were cultured without mouse embryonic fibroblast

Mouse zygote collection and culture
Three- to four-week-old female CD1 mice were superovulated by intraperitoneal (i.p.) injection of pregnant mare
serum gonadotropin (Merck Animal Health, Canada) followed by i.p. injection of human chorionic gonadotropin
(Merck Animal Health) 48 h later. Female mice were then
singly housed with male mice for mating. The following
morning, female mice were checked for the presence of a
vaginal plug. Females with vaginal plugs were euthanized and
oviducts were dissected. Zygotes were collected by flushing
the oviducts with M2 medium (Sigma-Aldrich, Canada). To
remove cumulus cells, zygotes were briefly incubated in M2
medium containing hyaluronidase (Zenith Biotech). Zygotes
were washed through drops of M2 medium, followed by

Table 1. siRNA Sequences
p66Shc
siRNA
No. 1
Scrambled
siRNA
No. 1
p66Shc
siRNA
No. 2
Scrambled
siRNA
No. 2

Sense: UGAGUCUCUGUCAUCGCUGtt
Antisense: CAGCGAUGACAGAGACUCAtt
Sense: AUGCGUCGCGAUUAUAUCUtt
Antisense: AGAUAUAAUCGCGACGCAUgc
Sense: ACAACCCACUUCGGAAUGAtt
Antisense: UCAUUCCGAAGUGGGUUGUac
Sense: AGCCGUCAAUCACUACAGUtt
Antisense: ACUGUAGUGAUUGACGGCUUc
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feeders on 0.1% gelatin in KO DMEM/F12/Neurobasal
media (Life Technologies) supplemented with 1% N2, 2%
B27 (Life Technologies), 1,000 U/mL mouse LIF (Esgro;
Millipore), 3 mM CHIR99021 (Selleck Chemicals), and 1 mM
PD0325901 (Selleck Chemicals). Cells were transfected with
60 pmol of siRNA with Lipofectamine 3000 (Thermo Fisher
Scientific) according to manufacturer’s protocols. Twentyfour hours post siRNA transfection, cells were lysed in
radioimmunoprecipitation assay (RIPA, 150 mM NaCl, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM
Tris) buffer for immunoblotting.

Quantitative real time reverse transcription-PCR
RNA was extracted from pools of 20 cleavage stage embryos or 10 blastocysts using the PicoPure RNA Isolation Kit
(Thermo Fisher Scientific) according to manufacturer’s instructions. During extraction, RNA was incubated with RNaseFree DNase I (Qiagen, Canada) to digest genomic DNA from
the samples. RNA was reverse transcribed to cDNA using
SuperScript III (Thermo Fisher Scientific) according to the
manufacturer’s instructions with the following modifications:
priming was done with random hexamers (Thermo Fisher
Scientific) and a gene-specific reverse primer [14]. Quantitative real-time PCR was performed on a CFX384 thermal
cycler (Bio-Rad, Canada) using SensiFAST SYBR (FroggaBio,
Canada) and a final concentration of 400 nM primers with the
following cycling conditions: 95C for 2 min, 39 cycles of 95
for 5 s, 60C for 10 s, and 72C for 20 s. Ct values were obtained
from Bio-Rad CFX Manager 3.1 (Bio-Rad). Relative transcript
abundance was determined by using the delta-delta Ct method
using the geometric mean of Ct values of Ppia and Hprt for
normalization. Primer sequences are found in Table 2.

Immunoblotting
Cells and embryos were lysed in RIPA buffer containing
protease and phosphatase inhibitors (Millipore) and stored at
-80C until processing. Total protein lysates were resolved
on a 4%–12% Bis-Tris polyacrylamide gel (Thermo Fisher
Scientific) and transferred to a PVDF membrane (Millipore).

Membranes were blocked in either 5% skim milk in TBST
for 1 h at room temperature. Membranes were then incubated
in primary antibody diluted in 5% skim milk in TBST
overnight at 4C at the following dilutions: mouse anti-Shc
(610879, 1:500; BD Biosciences), rabbit anti-CDX2
(ab76541, 1:500; Abcam), and rabbit anti-EOMES (ab23345,
1:1,000; Abcam). Membranes were then incubated in HRPconjugated secondary antibody (1:2,000; Jackson Laboratories) diluted in 5% skim milk or BSA in TBST for 1 h at
room temperature before ECL detection (Luminata Forte;
Millipore). Western blot images were taken with a ChemiDoc
Imaging System (Bio-Rad) and densitometry analysis of band
intensity was performed in ImageLab 4.0 (Bio-Rad). Membranes were then stripped for 20 min using Antibody Stripping Buffer (FroggaBio), then blocked and probed with
mouse anti-b-actin-HRP (A3854, 1:10,000; Sigma).

Immunofluorescence and confocal microscopy
Embryos were fixed in 2% paraformaldehyde in PBS for
30 min at room temperature. Embryos were then permeabilized in 0.25% Triton X-100 in PBS for 30 min, blocked in 5%
normal goat serum in PBS, and incubated overnight at 4C in
the following primary antibodies: mouse anti-NT-Shc
(AM00143PU-N, 1:100, validated in Edwards et al. [14];
Acris), mouse anti-OCT3/4 (C-10, sc-5279, 1:50, Nichols
et al. [7]; Santa Cruz Biotech), goat anti-GATA4 (sc-1237,
1:200, Nichols et al. [7]; Santa Cruz Biotech), rabbit anticleaved caspase-3 (AF835, 1:50; R&D Systems), rabbit antiCDX2 (1:100, [18]; Abcam), rabbit anti-NANOG (RCAB001P,
1:200; ReproCell), goat anti-SOX17 (AF1924, 1:100; R&D
Systems), and rabbit anti-DUSP4 (ab216576, 1:200; Abcam).
Embryos were then incubated at room temperature for 1 h
in either Alexa Fluor 488- or 594-conjugated secondary
antibodies (Thermo Fisher Scientific), and mounted in
VECTASHIELD Antifade solution (Vector Laboratories)
on a glass microscopy slide. Confocal microscopy was
performed with a Zeiss LSM510 laser scanning confocal
microscope with 10 z-sections taken through each blastocyst (mean z-stack step size = 6.83 mM, max = 9.324 mM,

Table 2. Primer Sequences
Gene
p66Shc
Cdkn1a
Rb1
Trp53
Gadd45a
Dusp4
Ppia
Hprt

Sequences

Expected product size, bp

F: 5¢-CCGACTACCCTGTGTTCCTTCTT-3¢
R: 5¢-CCCATCTTCAGCAGCCTTTCC-3¢
F: 5¢-TCCAGACATTCAGAGCCACAGG-3¢
R: 5¢-ACGGGACCGAAGAGACAACG-3¢
F: 5¢-CTTGCATGGCTTTCAGATTCACCT-3¢
R: 5¢-ATGGTTACCCTGGAGAGGCAG-3¢
F: 5¢-GGACCATCCTGGCTGTAGGT-3¢
R: 5¢-GGCAGTCATCCAGTCTTCGG-3¢
F: 5¢-TGCTGGTGACGAACCCACAT-3¢
R: 5¢-CATGTAGCGACTTTCCCGGC-3¢
F: 5¢-AAACTGGGTGCCGTTCAGAT-3¢
R: 5¢-AACACCCAATGTATCCGCGA-3¢
F: 5¢-GTCCTGGCATCTTGTCCATG-3¢
R: 5¢-TGCCTTCTTTCACCTTCCCA-3¢
F: 5¢-GCTTACCTCACTGCTTTCCG-3¢
R: 5¢-ATCATCGCTAATCACGACGC-3¢

111
97
117
113
86
116
126
128
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min = 4.957 mM). Laser settings were unchanged when detecting the same primary antibody between treatment groups.
Nuclei with detectable antibody staining were manually
counted in duplicate in ImageJ (National Institutes of Health).
For fluorescence intensity quantification of p66Shc knockdown, 3D z-stack projections were created in ZEN Black (Zeiss,
Germany) exported as TIFF files and opened in ImageJ. Images
were converted to grayscale and LUT inverted. The mean gray
value was measured, and the average mean gray value of three
images of embryos with no primary antibody was subtracted to
control for background fluorescence. To quantify OCT3/4 immunofluorescence intensity in blastocysts, individual z-stacks
were analyzed by Modular Interactive Nuclear Segmentation
(MINS, [19] and the fluorescence intensity of OCT3/4 of nuclei
detected by the software was determined and averaged.

BrdU incorporation assay
Embryos were incubated in KSOMaa containing 10 mM
of bromodeoxyuridine (BrdU; Acros Organics) for 45 min
before fixation with 2% paraformaldehyde. Embryos were
then processed for immunofluorescence as described above
with the following additions: after permeabilization, embryos were incubated in 300 mg/mL DNase for 30 min at
37C [20]. Embryos were incubated overnight at 4C in
mouse anti-BrdU antibody (G3G4, 1:100; Developmental
Studies Hybridoma Bank deposited by Kaufman, S.J.), then
incubated at room temperature for 1 h in goat anti-mouse
Alexa Fluor 488 (1:400). Confocal microscopy was performed as described above.

Statistical analyses
Statistical tests were performed using Prism 6 (GraphPad
Inc.) for Students’ t-test (unpaired, two-tailed with equal
variance) or Fisher’s exact test (two-tailed). At least three
independent replicates were performed for each experiment.

Results
Specific knockdown of p66Shc in mouse
preimplantation embryos
To target p66Shc for knockdown by RNAi, two different
siRNA sequences were designed to recognize the unique Nterminal exon of the p66Shc transcript variant of mouse Shc1
(sequences in Table 1). Fifty micrometer of each sequence,
designated Nos. 1 and 2, and its associated control (scrambled
nucleotide) sequence was microinjected into the cytoplasm of
zygotes. Pools of embryos were then collected at different time
points post siRNA injection to assess knockdown efficiency by
quantitative real-time reverse transcription-PCR. We were
unable to detect a statistically significant decrease in p66Shc
transcript abundance 24 h post siRNA No. 1 injection due to the
high variability of p66Shc transcript levels in control 2-cell
embryos [14] (Fig. 1A). However, p66Shc transcript abundance
significantly decreased to 33% of control levels in embryos injected with p66Shc siRNA No. 1 48 h postinjection (P < 0.05,
Fig. 1A). By 72 and 96 h postinjection, p66Shc transcript
abundance levels in embryos injected with p66Shc siRNA
became comparable to controls (Fig. 1A). P66Shc siRNA sequence No. 2 also significantly knocked down p66Shc transcript abundance 48 h post siRNA injection (Supplementary
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Fig. S1A; Supplementary Data are available online at
www.liebertpub.com/scd). Due to the higher knockdown efficiency at 48 h postinjection, the remaining experiments were
performed with sequence No. 1. Some experiments were repeated using siRNA sequence No. 2 to confirm gene-specific
phenotypes (eg, Supplementary Fig. S3).
To confirm knockdown at the protein level, zygotes were
injected with siRNA No. 1 sequences, fixed at 24, 48, and 72 h
postinjection, and stained for p66Shc immunofluorescence.
Significant decreases in p66Shc fluorescence intensity were
detected at all three time points post siRNA injection, with the
greatest reduction in fluorescence intensity observed at 48 h
post siRNA injection (29% of control levels, P < 0.0001,
Fig. 1B, additional microscopy pictures in Supplementary
Fig. S2). Thus, our results demonstrate that 50 mM of p66Shcspecific siRNA significantly reduces p66Shc transcript and
protein levels during mouse preimplantation development.
Knockdown specificity and efficiency was confirmed in R1
mouse embryonic stem cells (Supplementary Fig. S1B).

P66Shc knockdown embryos form blastocysts
containing more TE cells
We next determined if embryos receiving p66Shc siRNA
could form blastocysts. Blastocyst formation did not significantly change in embryos receiving p66Shc siRNA compared
with controls with frequencies of blastocyst development observed between 60% and 70% of all cultured 2-cell embryos
(Fig. 2A) and no significant changes in cavitation (Fig. 2B).
Blastocysts formed by embryos that received p66Shc siRNA
were morphologically similar to scrambled siRNA-injected
controls (Fig. 2C). However, p66Shc knockdown blastocysts
contained, on average, 12 more cells than scrambled controls
at 96 h postinjection (*70 cells in p66Shc knockdown embryos
compared with 58 in scrambled controls, Fig. 2D, middle
panel). Embryos not injected with siRNA formed blastocysts
with an average of 64 cells after 96 h of culture, suggesting that
introduction of siRNA oligonucleotides does not significantly
affect cell viability in the embryo (Supplementary Fig. S3A).
Interestingly, p66Shc knockdown embryos at 72 h postinjection
contained significantly fewer cells than scrambled controls,
whereas p66Shc knockdown embryos at 120 h postinjection
contained cell numbers comparable to controls (Fig. 2D). Our
results thus demonstrate that although embryos with p66Shc
knockdown can form blastocysts, they produce blastocysts with
more total cells than controls 4 days after p66Shc siRNA introduction.
Due to p66Shc knockdown affecting blastocyst total cell
number, we next investigated its effects on cell apoptosis and
proliferation at 96 h post siRNA injection. There was no significant difference in the percentage of cleaved caspase-3positive cells in p66Shc knockdown blastocysts compared
with controls, suggesting that apoptosis is not contributing to
the change in total cell number (Fig. 3A). However, p66Shc
knockdown blastocysts at 96 h displayed significantly increased BrdU incorporation, suggesting that altered proliferation may lead to the increased total cell number observed
(Fig. 3A). When stained for markers of the TE (CDX2)
and ICM (OCT3/4, SOX2), we observed that p66Shc knockdown blastocysts had on average more CDX2-positive cells
compared with scrambled controls, whereas the average number of OCT3/4-positive cells was comparable between groups

FIG. 1. p66Shc siRNA reduces p66Shc transcript and protein abundance in mouse preimplantation embryos. (A) RTqPCR was performed on pools of 20 embryos or 10 blastocysts at four time points postinjection of 50 mM siRNA (24 h N = 5
pools of embryos, 48 h N = 4, 72 h N = 4, 96 h N = 3). P66Shc transcript abundance is significantly reduced at 48 h post
siRNA injection (mean – SD, *P < 0.05, Student’s t-test). (B) Immunofluorescence and confocal microscopy for p66Shc
protein was performed on embryos taken at three time points post siRNA injection. The relative fluorescence intensities of
z-stack projections were quantified. P66Shc fluorescence intensity was significantly decreased at 24 (n = 15 embryos), 48
(n = 17), and 72 h (n = 14) post p66Shc-siRNA injection compared with controls (mean – SEM, *P < 0.05, **P < 0.01,
****P < 0.00001, Student’s t-test). Scale bars are 20 mm. RT-qPCR, reverse transcription-quantitative polymerase chain
reaction; siRNA, short interfering RNA.
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FIG. 2. p66Shc knockdown embryos form blastocysts containing more cells than controls. (A) Embryos receiving p66Shc
siRNA form blastocysts at equivalent rates to scrambled controls (N = 3 experimental replicates, mean – SD). (B) p66Shc
knockdown embryos form blastocyst cavities at similar rates to scrambled controls (N = 3 pools of 14 embryos, mean – SEM). (C)
p66Shc knockdown embryos form morphologically similar blastocysts compared with scrambled controls (scale bars = 100 mm).
(D) Total cell number in p66Shc knockdown embryos is significantly lower than controls at 72 h post siRNA injection (n = 15 per
group, *P < 0.05, Student’s t-test), significantly higher than controls at 96 h post siRNA injection (n = 25 per group, *P < 0.05,
Student’s t-test) and not significantly different at 120 h post siRNA injection (n = 41 per group). Graphs are the mean – SEM.
(Fig. 3B). We confirmed in an independent experiment that
the number of inner cells is unchanged in p66Shc knockdown
blastocysts compared with scrambled controls by SOX2
immunostaining (Fig. 3C). Therefore, the increase in total
cell number of p66Shc knockdown blastocysts is likely due
to altered proliferation of the TE and not the ICM. Interestingly, p66Shc knockdown blastocysts had significantly reduced Rb1 transcript abundance compared with controls,
suggesting that the cell cycle may be altered in these embryos
(Fig. 3D).

P66Shc knockdown accelerates the onset of PE
marker expression in mouse blastocysts
Although p66Shc knockdown embryos formed blastocysts
at the same frequency and appeared morphologically similar

to controls, we next investigated the effects of p66Shc
knockdown on cell differentiation to the TE and ICM lineages. To investigate this directly, we processed blastocysts
96 h post siRNA injection for immunofluorescence and
confocal microscopy for CDX2 and OCT3/4, definitive
markers of the TE and ICM, respectively. Some blastocysts
contained cells positive for both CDX2 and OCT3/4, which
is consistent with the finding that all cells of the early
blastocyst initially express OCT3/4 before its expression is
restricted to the inner cells [21]. Notably, 60% of p66Shc
knockdown blastocysts showed OCT3/4 restriction to the
inner cells compared with 25% of scrambled control blastocysts when fixed at 96 h post siRNA injection (Fig. 4A, B).
To quantify this difference in staining pattern, we determined
the total cell number and categorized embryos from both
groups into blastocysts containing 32–64 cells or blastocysts
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FIG. 3. Altered cell proliferation
in p66Shc knockdown blastocysts.
(A) p66Shc knockdown blastocysts
have similar levels of cleaved
caspase-3 cells compared with controls (n = 16, mean – SEM, white
asterisks indicate cells positive
for cleaved caspase-3). However,
p66Shc knockdown blastocysts have
a significantly increased percentage
of cells positive for BrdU incorporation after 45 min of incubation
compared with controls (n = 46,
*P < 0.05, mean – SEM, Student’s
t-test). (B) p66Shc knockdown blastocysts have a significant increase in
the number of CDX2-positive cells
compared with scrambled controls,
whereas the number of OCT3/4positive cells is unchanged between groups (n = 26, mean – SEM,
***P < 0.001, Students’ t-test). (C)
p66Shc knockdown blastocysts have
similar numbers of SOX2-positive
cells compared with scrambled controls (n = 33, mean – SEM, Students’
t-test). (D) RT-qPCR was performed
on pools of 10 blastocysts for transcript abundance of cell cycle
markers. P66Shc knockdown blastocysts have significantly lower Rb1
transcript abundance compared with
controls (N = 3 pools of 10 embryos,
*P < 0.05, mean – SD, Student’s ttest).

containing 64–128 cells, then counted the number of cells
positive for both CDX2 and OCT3/4 (double positive). In
32–64-cell blastocysts, p66Shc knockdown blastocysts contained approximately the same percentage of double-positive
nuclei. However, at the 64–128-cell stage, p66Shc knockdown embryos contained a significantly lower percentage of
double-positive nuclei, supporting the observation that
OCT3/4 expression is restricted earlier in p66Shc knockdown blastocysts compared with controls (Fig. 4C, D).
We observed that OCT3/4 fluorescence intensity appeared to be elevated in the inner cells of 32–64-cell p66Shc

knockdown blastocysts compared with scrambled controls.
Quantification of OCT3/4 fluorescence intensity revealed
that on average, nuclei of p66Shc knockdown blastocysts
had significantly increased OCT3/4 immunofluorescence
intensity than scrambled controls (Fig. 4E). This difference
is lost in 64–128-cell blastocysts, suggesting that there is a
transient window in which OCT3/4 expression is elevated in
the inner cells of p66Shc knockdown blastocysts (Fig. 4F).
In contrast, protein abundance of CDX2 and EOMES determined by immunoblotting were unaffected by p66Shc
knockdown, suggesting that p66Shc knockdown does not
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FIG. 4. Elevated OCT3/4 levels and earlier restriction of OCT3/4 to the inner cells in p66Shc knockdown blastocysts.
Embryos were categorized according to cell number before analysis: 32–64 cells (scrambled mean – SD = 51.94 – 8.33,
p66Shc KD mean = 49.60 – 7.93) or 64–128 cells (scrambled mean = 71.38 – 5.48, p66Shc KD mean = 74.76 – 4.46). (A)
Representative confocal microscopy images of scrambled and p66Shc knockdown 32–64-cell blastocysts immunostained
for CDX2 and OCT3/4. Scale bars are 20 mm. (B) Representative confocal microscopy images of scrambled and p66Shc
knockdown 64–128-cell blastocysts. Scale bars are 20 mm. (C) p66Shc knockdown blastocysts have similar CDX2-positive/
OCT3/4-positive nuclei compared with scrambled controls in 32–64-cell blastocysts (n = 19, mean – SEM, Students’ t-test).
(D) p66Shc knockdown blastocysts have significantly fewer CDX2-positive/OCT3/4-positive nuclei in 64–128-cell blastocyst (n = 23, *P < 0.05, mean – SEM, Student’s t-test). (E) p66Shc knockdown blastocysts have significantly higher
nuclear OCT3/4 fluorescence intensity compared with scrambled controls in 32–64-cell blastocysts (n = 19, *P < 0.05,
mean – SEM, Student’s t-test). (F) p66Shc knockdown blastocysts have no significant changes in nuclear OCT3/4 fluorescence intensity compared with scrambled controls (n = 23, mean – SEM). KD, knockdown.

affect the relative abundance of TE markers in the blastocyst
(Supplementary Fig. S3B). Our results thus demonstrate that
p66Shc knockdown causes altered proliferation in the TE,
increased OCT3/4 expression in the ICM of early blastocysts, and faster restriction of OCT3/4 to the inner cells of
the blastocyst.
Since OCT3/4 is restricted earlier to the inner cells in
p66Shc knockdown blastocysts, we hypothesized that the
ICMs in these embryos might be more developmentally
advanced with regard to their differentiation program and
may be specifying EPI versus PE fate earlier than controls.
Furthermore, increased OCT3/4 expression is associated
with endoderm differentiation in blastocysts and embryonic
stem cells [22,23]. To investigate this, blastocysts were fixed
and processed for immunofluorescence for GATA4 and
NANOG, markers of the PE and EPI fates, respectively
(Fig. 5A). In 32–64-cell p66Shc knockdown blastocysts, we
observed that the percentage of total cells and inner cells
expressing GATA4 was significantly higher than that for
scrambled controls (Fig. 5B and Supplementary Fig. S3C).
This increase in the GATA4-positive cell proportion of in-

ner cells was at the expense of NANOG-positive cells, and
not due to selective proliferation of GATA-positive cells, as
the total number of inner cells was unchanged between
knockdown and control blastocysts (Fig. 5C, D). The percentage of GATA4-positive cells of total cells was also
significantly increased in embryos receiving p66Shc siRNA
sequence No. 2, verifying a gene-specific phenotype (Supplementary Fig. S3C). To further confirm our findings, we
immunostained blastocysts for SOX17, an earlier marker of
PE specification (Fig. 5E). We observed that like GATA4,
the percentage of inner cells expressing SOX17 was significantly increased in p66Shc knockdown blastocysts
compared with scrambled controls (Fig. 5F).
As ICM cells are not committed until the late blastocyst
stage [5], we investigated whether the increase in cells
adopting a PE fate in p66Shc knockdown blastocysts persisted in late blastocysts. Blastocysts were cultured up to
120 h post siRNA injection, then fixed and processed for
GATA4, SOX17, and NANOG immunofluorescence. We
observed a significant increase in the percentage of GATA4positive cells of total inner cells and a decreased percentage

FIG. 5. Knockdown of p66Shc increases the number of cells expressing PE markers in the inner cell mass of 32–64-cell
blastocysts (A) Blastocysts were fixed and processed for immunofluorescence and confocal microscopy 96 h post siRNA
injection. Panels display representative confocal microscopy images. Scale bars are 20 mm. P66Shc knockdown blastocysts
have significantly increased percentage of inner cells positive for GATA4 (B) and significantly decreased percentage
positive for NANOG (C) (n = 19 per group, mean – SEM, ****P < 0.0001, Student’s t-test). (D) The total cell number of the
inner cell mass was not significantly different between p66Shc knockdown embryos and controls (n = 19 per group,
mean – SEM, Student’s t-test). (E) Blastocysts were processed for immunofluorescence for SOX17 and NANOG. Panels
display representative confocal microscopy images. Scale bars are 20 mm. (F) The percentage of SOX17 cells of total inner
cells is significantly increased in p66Shc knockdown blastocysts compared with scrambled controls (n = 22, mean – SEM,
*P < 0.05, Student’s t-test). PE, primitive endoderm.
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of NANOG-positive cells in p66Shc knockdown blastocysts
(Fig. 6A, B). Additionally, the percentage of SOX17-positive
cells of inner cells in late p66Shc knockdown blastocysts was
significantly increased compared with scrambled controls
(Fig. 6C). The total number of inner cells did not signifi-
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cantly change between groups, nor did it significantly increase from 32- to 64-cell blastocysts, suggesting that some
GATA4-positive cells may have altered their fate to become
NANOG-positive (Fig. 6D). Additionally, when blastocysts
were categorized based on their GATA4 and NANOG

FIG. 6. Knockdown of p66Shc accelerates sorting of the PE in 64–128-cell blastocysts. (A) Blastocysts were processed for
immunofluorescence and confocal microscopy 120 h post siRNA injection. p66Shc knockdown late blastocysts had a significant
increase in the percentage of inner cells positive for GATA4 (B), a significant decrease in cells positive for NANOG (C) (n = 41
blastocysts, mean – SEM, *P < 0.05, Student’s t-test), and a significant increase in the percentage of inner cells positive for SOX17
(C) (n = 22 blastocysts, mean – SEM, ***P < 0.001, Student’s t-test). (D) Total number of cells in the inner cell mass is not
significantly different in p66Shc knockdown embryos compared to controls (n = 41 blastocysts). (E) In 64–128-cell embryos,
p66Shc knockdown blastocysts also had a significantly higher proportion of embryos displaying sorted PE staining compared with
scrambled controls (n = 41 blastocysts per group, *P < 0.05, Fisher’s exact test). Scale bars are 20 mm. (F) Bright field microscopy of
in vitro blastocyst outgrowths. A significantly lower proportion of p66Shc knockdown blastocysts formed inner cell mass-derived
outgrowths (asterisks) compared with scrambled controls (n = 23 and 24 outgrowths per group, *P < 0.05, Fisher’s exact test).
Numbers in the image panels indicate the number of outgrowths resembling the displayed morphology. Scale bars are 100 mm.
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staining pattern to determine the extent of PE sorting [24],
36% of p66Shc knockdown blastocysts contained GATA4positive cells categorized as sorted, versus only 14% of the
control blastocyst population containing sorted GATA4positive cells (Fig. 6E). Altogether, our results suggest that
not only does the differences in EPI and PE cell proportions
in p66Shc knockdown blastocysts persist until 120 h post
siRNA injection, but these blastocysts also show much earlier sorting of PE cells to the PE layer.
We next determined if the reduction of NANOG-expressing
cells in the ICMs of p66Shc knockdown blastocysts would
negatively affect EPI survival in vitro. Blastocysts were plated
in conditions supporting embryonic stem cell derivation (eg,
EPI survival) for 5 days and then assessed for the presence of
an ICM-derived outgrowth or cell mass (Fig. 6F). We observed that only 46% of p66Shc siRNA-injected blastocysts
formed detectable ICM cell masses (n = 11 of 24). Fifty-four
percent of p66Shc knockdown blastocysts did not form an
ICM-derived outgrowth from 72 h of culture onward, suggesting that the EPI population from these blastocysts did not
survive (n = 13 of 24, Supplementary Fig. S4A). ICM-derived
outgrowths formed from scrambled blastocysts stained positive for OCT3/4 (EPI) and GATA4 (endoderm) (n = 8 of 8),
whereas outgrowths from p66Shc knockdown blastocysts with
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no ICM cell mass had disorganized and diffuse OCT3/4 and
GATA4 immunostaining, suggesting that neither the EPI
nor the PE survived during outgrowth formation (n = 4 of 7,
Supplementary Fig. S4B). The remaining three p66Shc
knockdown outgrowths that formed an ICM clump stained
positive for OCT3/4 and GATA4 staining, suggesting that
some p66Shc knockdown blastocysts may have a critical
number of NANOG-positive cells required for survival of the
ICM in vitro, whereas the majority do not. Our results suggest
that p66Shc knockdown in preimplantation embryos may affect the survival of the ICM in vitro.

p66Shc knockdown increases the number
of DUSP4-positive cells in the blastocyst
As the adoption of PE fate in the ICM is dependent on
FGF4/MAPK signaling [5,7], we next determined if decreased p66Shc levels resulted in a greater number of cells
expressing PE markers to emerge due to increased or inappropriate MAPK signaling. Like previous studies [6], we
were unable to detect phosphorylated-ERK1/2 in ICM cells
by immunofluorescence. Although we attempted localization of total-ERK1/2 to detect nuclear translocation of
ERK1/2, we encountered high background staining by

FIG. 7. p66Shc knockdown
blastocysts
displayed
altered
ERK1/2 activity. (A) p66Shc
knockdown blastocysts had a significant increase in cells positive
for DUSP4, an ERK1/2 transcriptional target downstream of FGF/
MAPK signaling, compared with
controls (n = 13 blastocysts, mean –
SEM, *P < 0.05). (B) When treated
with 1 mM PD0325901, all cells of
the inner cell mass of p66Shc
knockdown blastocysts were NANOG positive (n = 17 blastocysts
per group). Scale bars are 20 mm.
ERK, extracellular signal-regulated
kinase; FGF, fibroblast growth
factor; MAPK, mitogen-activated
protein kinase.
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immunofluorescence and confocal microscopy (Supplementary Fig. S5A). To overcome the challenge of reliably
detecting ERK1/2 activation, we proceeded to define
DUSP4 localization, a transcriptional target of FGF4MAPK signaling specific to ICM cells committing to the PE
fate [25]. Accordingly, we observed DUSP4 colocalization
with GATA4 in blastocysts (Fig. 7A). We did not observe a
significant change in DUSP4-positive cells or Dusp4 transcript abundance in embryos 72 h post siRNA injection
(Supplementary Fig. S5B). However, p66Shc knockdown
blastocysts at 96 h post siRNA injection contained a significantly higher percentage of DUSP4-positive cells compared with scrambled controls, suggesting that these
blastocysts have more cells with active ERK1/2 compared
with controls (Fig. 7A). The increased proportion of PE cells
in the ICM of p66Shc knockdown blastocysts was reversed
by ERK1/2 inhibition, as treatment for 24 h with 1 mM
PD0325901 resulted in all inner cells of p66Shc knockdown
blastocysts to become NANOG positive at 96 h post siRNA
injection (Fig. 7B). Altogether, our results support that decreased expression of p66Shc is associated with an increase
in the number of cells in the blastocyst with active ERK1/2,
and that the increase in GATA4-positive cells in the ICM is
reversible by MEK1/2 inhibition.

Discussion
In this study, we show a novel role for p66Shc during
mouse preimplantation development, demonstrating that
p66Shc is mechanistically linked to the expression dynamics
of blastocyst lineage-associated transcription factors. Our
results demonstrate that knockdown of p66Shc during preimplantation embryo development affects the abundance and
restriction of OCT3/4 and the number of cells expressing
markers of the PE (GATA4, SOX17) in the ICM. Knockdown
of p66Shc in mouse embryos leads to blastocysts with more
GATA4-positive cells than NANOG-positive cells in the
ICM compared with controls. This imbalance is partially resolved by the late blastocyst stage, but PE cells appear to sort
to the PE layer earlier in knockdown blastocysts compared
with controls. When plated in vitro, p66Shc knockdown
blastocysts have a decreased ability to generate ICM-derived
outgrowths compared with controls. Furthermore, decreased
p66Shc expression leads to an increased number of cells expressing DUSP4, and the increased proportion of GATA4expressing cells is rescued by ERK1/2 inhibition. Our study
also suggests a possible novel role for p66Shc in regulating
the cell signaling that results in the commitment to extraembryonic endoderm.
Regulation of cell fate-associated transcription factor
expression is a novel proposed function for p66Shc, as the
gene has thus far been shown to negatively regulate embryo development by promoting apoptosis and senescence
(embryo arrest). However, many of these effects were
stimulated by stressful environmental conditions, including
treatment with H2O2 [16] and arsenic [17]. In these cases,
p66Shc may act to ensure that embryos unable to adapt to
stress do not continue to develop by inducing mitochondrial
ROS to promote apoptosis or embryo arrest. In contrast to
studies with bovine embryos, we did not observe a significant increase in the number of embryos developing into
blastocysts after p66Shc knockdown compared with con-
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trols, suggesting that knockdown of p66Shc in our experimental model did not improve basal levels of blastocyst
development [15]. Interestingly, our results also suggest that
p66Shc knockdown blastocysts may be more developmentally
advanced than controls, which suggests that they are following
the developmental timeline of embryos developing in vivo. It is
well known that late blastocyst development is delayed in
embryos cultured in vitro relative to their in vivo counterparts
[21]. However, culture does not appear to significantly alter the
timing of lineage-specific marker patterning, as in vivo derived
blastocysts also show initial OCT3/4 expression in the TE until
the late blastocyst stage [21]. This apparent developmental
advancement in p66Shc knockdown embryos may be due to
enhanced stress resistance to the culture environment conferred by reduced p66Shc expression.
We were unable to detect differences in MAPK signaling
between p66Shc knockdown and control embryos at 72 h
post siRNA injection, when p66Shc protein expression is
still significantly decreased by RNAi. Instead, we observed
phenotypic differences at the blastocyst stage, when the
knockdown effect is no longer present at the transcriptional
level. RNA interference using siRNAs is a limitation of our
study as knockdown effects did not persist at the transcript
level to the blastocyst stage [14,15]. However, due to protein turnover and stability, the timing of maximal phenotypic effects does not necessarily correspond to maximal
knockdown effects. Several studies using siRNA to knockdown p66Shc in preimplantation embryos also observe
restoration of p66Shc transcript levels to wild-type levels at
the blastocyst stage, but the transient knockdown of p66Shc
during preimplantation development significantly affected
the ability of blastocysts to develop under basal and stressinducing culture conditions [15–17]. Our results suggest that
transient knockdown of p66Shc up to 72 h of development
has an effect on cell-lineage transcription factor expression
at the blastocyst stage. This could be through affecting
earlier events in PE specification such as differences in
FGF4/FGFR2 signaling that first occurs in the early ICM
[26], or through regulating the levels of OCT3/4 in morulae
that in turn would affect FGF4 levels [21,27]. Additionally,
there may be effects of p66Shc on other signaling pathways
that have not yet been identified but are independently required for the onset of Gata6 expression [6].
Interestingly, EPI survival was reduced in vitro in p66Shc
knockdown blastocysts as significantly fewer blastocysts
produced ICM outgrowths compared with scrambled controls. We did not test whether p66Shc knockdown enhanced
the survival of the PE or the TE in vitro. We speculate that the
derivation of extraembryonic endoderm and/or trophoblast
stem cells may be enhanced in p66Shc knockdown blastocysts due to the increased number of cells positive for GATA4
(PE) and CDX2 (TE) observed at the blastocyst stage. We did
not quantify this as the conditions we used (knockout serum
replacement [KOSR] and leukemia inhibitory factor [LIF])
predominately support EPI survival [28]. The importance of
p66Shc to pre- and periimplantation survival is still not well
understood. P66Shc KO mice survive embryonic development, however, it is unclear whether mating between homozygous null mice was tested [13]. P66Shc mRNA and/or
protein stored in the oocyte of female heterozygous KO mice
may produce a maternal rescue of a preimplantation phenotype. However, when exposed to natural environmental
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conditions (eg, not a controlled laboratory environment),
p66Shc KO mice have reduced fertility with repeated
breeding cycles [29]. To this end, our future experiments are
being directed toward producing maternal and embryonic
genetic KO models of p66Shc in preimplantation embryos
and the production of these lines will determine the extent of
p66Shc regulation of OCT3/4 expression during preimplantation development, its requirement for establishing cell fate
in the ICM, and the consequences of its loss on fetal and
postpartum development.
Knockdown of p66Shc during mouse preimplantation development resulted in morphologically normal blastocysts.
However, we detected an increased total cell number in
p66Shc knockdown blastocysts compared with controls, and
attribute this increase to altered proliferation in the TE.
p66Shc has not been extensively linked with cell cycle regulation in other studies, but it could indirectly affect cell
proliferation through regulating epidermal growth factor receptor (EGFR) signaling activity [11]. The time frame for
altered proliferation is short, as knockdown embryos 72 h post
siRNA injection contained fewer total cells, and knockdown
embryos 120 h postinjection did not significantly differ in cell
number than controls.
After investigating the transcript levels of cell cycle markers, we observed a significant decrease in Rb1 transcript
abundance in p66Shc knockdown blastocysts. Rb1 restricts the
G1/S checkpoint of the cell cycle by binding and repressing
E2F transcription factors [30]. Regulation of RB1 function is
typically by phosphorylation and not by transcriptional regulation. However, RB1 is involved in promoting self-renewal
and repressing pluripotency networks, including OCT3/4 and
SOX2 expression, independent of the cell cycle [31,32]. The
increase in OCT3/4 expression in p66Shc knockdown blastocysts observed in our study could be functionally linked to the
decreased Rb1 transcript abundance. The effects of p66Shc
knockdown to other key cell cycle genes (Ccnd1, Ccne1)
would be useful and would provide insight into the role of
p66Shc in cell cycle regulation in the mouse blastocyst. Other
studies with EPI/PE imbalance phenotypes also have altered
proliferation, suggesting that the cell cycle may be linked to
cell fate specification in the mouse blastocyst [33,34].
We observed significantly higher OCT3/4 levels, faster
restriction of OCT3/4 to the inner cells of the blastocyst with
p66Shc knockdown, and a significantly increased proportion
of cells expressing PE markers (GATA4 and SOX17) in
p66Shc knockdown blastocysts. This increase in OCT3/4
levels could directly promote PE differentiation in the ICM of
p66Shc knockdown blastocysts. Palmieri et al. observed
higher OCT3/4 fluorescence intensity in the forming PE relative to the rest of the ICM, which led to speculation that
elevation of OCT3/4 levels may be a prerequisite to PE differentiation [22]. OCT3/4 is required to promote PE fate in the
mouse blastocyst by regulating the expression of FGF4 and
PE markers [27,35,36]. Additionally, a less than twofold
overexpression of OCT3/4 in embryonic stem cells is sufficient to promote endoderm differentiation [23]. Our work
suggests that PE marker expression may be a direct consequence of OCT3/4 elevation in the ICM. This raises the
possibility that p66Shc may regulate PE marker expression by
directly or indirectly regulating OCT3/4 levels in the ICM.
Our results suggest that the effects of p66Shc on the expression of SOX17 and GATA4 are mediated in part
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through ERK1/2 signaling. However, we did not directly
confirm that these effects were downstream or upstream of
FGF4 and cannot conclude that p66Shc regulates this specific pathway. No other signaling pathway aside from FGF4/
MAPK has been identified as being critical for promoting
PE marker expression and PE fate, and thus we speculate
that in the blastocyst p66Shc is acting as a canonical adaptor
protein to negatively regulate ERK1/2 activity downstream
of FGF4/RTK activation.
It is possible that p66Shc could be acting through another
RTK, such as EGFR, and ERK1/2 activity is regulated through
pathway crosstalk. For example, p66Shc overexpression is
associated with increased b-catenin activity in mouse embryonic stem cells undergoing directed neural differentiation,
which may be regulated through p66Shc-mediated generation
of ROS [37]. Although its interactions with the EGFR are the
most well studied, there is evidence that Shc proteins are recruited to and phosphorylated by FGFR1, 3, and 4, and indirectly associate with FGFR2 in vivo [38]. It is also possible that
FGFR1 versus FGFR2 expression is altered downstream of
p66Shc knockdown, which would affect the EPI/PE balance in
the ICM [25]. However, our results also suggest an intriguing
possibility that p66Shc may regulate this pathway by regulating OCT3/4 levels. P66Shc may ensure that OCT3/4 levels do
not reach a threshold that would promote PE marker expression and subsequent differentiation. Our work outlines an additional novel role of p66Shc in mouse blastocyst development
associated with the onset and relative abundance of lineageassociated transcription factors.
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